 | • レポートコード：D0804-16814 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腫瘍血液検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。腫瘍血液検査の種類別市場規模（血中タンパク質検査、腫瘍マーカー検査、その他）、用途別市場規模（病院、クリニック、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Guardant Health、Roche、Trovagene、Genomic Health、Pathway Genomics、Bio-Techne ・地域別グローバル市場分析 2015年-2020年 ・腫瘍血液検査の北米市場（アメリカ、カナダ、メキシコ） ・腫瘍血液検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腫瘍血液検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腫瘍血液検査の南米市場（ブラジル、アルゼンチン） ・腫瘍血液検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：血中タンパク質検査、腫瘍マーカー検査、その他 ・用途別分析：病院、クリニック、外来手術センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Tumor Blood Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tumor Blood Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
This report also the impact of Covid-19 outbreak on the Tumor Blood Testing industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Tumor Blood Testing and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Tumor Blood Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tumor Blood Testing market has been segmented into:
Blood Protein Testing
Tumor Marker Testing
Others
By Application, Tumor Blood Testing has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tumor Blood Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Tumor Blood Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tumor Blood Testing market.
The report offers in-depth assessment of the growth and other aspects of the Tumor Blood Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Tumor Blood Testing Market Share Analysis
Tumor Blood Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tumor Blood Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tumor Blood Testing sales, revenue and market share for each player covered in this report.
The major players covered in Tumor Blood Testing are:
Guardant Health
Roche
Trovagene
Genomic Health
Pathway Genomics
Bio-Techne
1 Tumor Blood Testing Market Overview
1.1 Product Overview and Scope of Tumor Blood Testing
1.2 Classification of Tumor Blood Testing by Type
1.2.1 Global Tumor Blood Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tumor Blood Testing Revenue Market Share by Type in 2019
1.2.3 Blood Protein Testing
1.2.4 Tumor Marker Testing
1.2.5 Others
1.3 Global Tumor Blood Testing Market by Application
1.3.1 Overview: Global Tumor Blood Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Tumor Blood Testing Market by Regions
1.4.1 Global Tumor Blood Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tumor Blood Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tumor Blood Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tumor Blood Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tumor Blood Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tumor Blood Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tumor Blood Testing Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Tumor Blood Testing Industry Impact
1.5.1 COVID-19 Potential Implications for the Tumor Blood Testing
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Tumor Blood Testing
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Guardant Health
2.1.1 Guardant Health Details
2.1.2 Guardant Health Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Guardant Health SWOT Analysis
2.1.4 Guardant Health Product and Services
2.1.5 Guardant Health Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Trovagene
2.3.1 Trovagene Details
2.3.2 Trovagene Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Trovagene SWOT Analysis
2.3.4 Trovagene Product and Services
2.3.5 Trovagene Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Genomic Health
2.4.1 Genomic Health Details
2.4.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Genomic Health SWOT Analysis
2.4.4 Genomic Health Product and Services
2.4.5 Genomic Health Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pathway Genomics
2.5.1 Pathway Genomics Details
2.5.2 Pathway Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pathway Genomics SWOT Analysis
2.5.4 Pathway Genomics Product and Services
2.5.5 Pathway Genomics Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Techne
2.6.1 Bio-Techne Details
2.6.2 Bio-Techne Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Techne SWOT Analysis
2.6.4 Bio-Techne Product and Services
2.6.5 Bio-Techne Tumor Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tumor Blood Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tumor Blood Testing Players Market Share
3.2.2 Top 10 Tumor Blood Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tumor Blood Testing Revenue and Market Share by Regions
4.2 North America Tumor Blood Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Tumor Blood Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tumor Blood Testing Revenue and Growth Rate (2015-2020)
4.5 South America Tumor Blood Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tumor Blood Testing Revenue and Growth Rate (2015-2020)
5 North America Tumor Blood Testing Revenue by Countries
5.1 North America Tumor Blood Testing Revenue by Countries (2015-2020)
5.2 USA Tumor Blood Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Tumor Blood Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Tumor Blood Testing Revenue and Growth Rate (2015-2020)
6 Europe Tumor Blood Testing Revenue by Countries
6.1 Europe Tumor Blood Testing Revenue by Countries (2015-2020)
6.2 Germany Tumor Blood Testing Revenue and Growth Rate (2015-2020)
6.3 UK Tumor Blood Testing Revenue and Growth Rate (2015-2020)
6.4 France Tumor Blood Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Tumor Blood Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Tumor Blood Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tumor Blood Testing Revenue by Countries
7.1 Asia-Pacific Tumor Blood Testing Revenue by Countries (2015-2020)
7.2 China Tumor Blood Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Tumor Blood Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Tumor Blood Testing Revenue and Growth Rate (2015-2020)
7.5 India Tumor Blood Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tumor Blood Testing Revenue and Growth Rate (2015-2020)
8 South America Tumor Blood Testing Revenue by Countries
8.1 South America Tumor Blood Testing Revenue by Countries (2015-2020)
8.2 Brazil Tumor Blood Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Tumor Blood Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tumor Blood Testing by Countries
9.1 Middle East & Africa Tumor Blood Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tumor Blood Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Tumor Blood Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Tumor Blood Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Tumor Blood Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tumor Blood Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Tumor Blood Testing Market Forecast by Type (2019-2024)
10.3 Blood Protein Testing Revenue Growth Rate (2015-2025)
10.4 Tumor Marker Testing Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Tumor Blood Testing Market Segment by Application
11.1 Global Tumor Blood Testing Revenue Market Share by Application (2015-2020)
11.2 Tumor Blood Testing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Tumor Blood Testing Market Size Forecast (2021-2025)
12.1 Global Tumor Blood Testing Market Size Forecast (2021-2025)
12.2 Global Tumor Blood Testing Market Forecast by Regions (2021-2025)
12.3 North America Tumor Blood Testing Revenue Market Forecast (2021-2025)
12.4 Europe Tumor Blood Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tumor Blood Testing Revenue Market Forecast (2021-2025)
12.6 South America Tumor Blood Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tumor Blood Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tumor Blood Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tumor Blood Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tumor Blood Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tumor Blood Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Tumor Blood Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Guardant Health Corporate Information, Location and Competitors
Table 7. Guardant Health Tumor Blood Testing Major Business
Table 8. Guardant Health Tumor Blood Testing Total Revenue (USD Million) (2017-2018)
Table 9. Guardant Health SWOT Analysis
Table 10. Guardant Health Tumor Blood Testing Product and Solutions
Table 11. Guardant Health Tumor Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Roche Corporate Information, Location and Competitors
Table 13. Roche Tumor Blood Testing Major Business
Table 14. Roche Tumor Blood Testing Total Revenue (USD Million) (2018-2019)
Table 15. Roche SWOT Analysis
Table 16. Roche Tumor Blood Testing Product and Solutions
Table 17. Roche Tumor Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Trovagene Corporate Information, Location and Competitors
Table 19. Trovagene Tumor Blood Testing Major Business
Table 20. Trovagene Tumor Blood Testing Total Revenue (USD Million) (2017-2018)
Table 21. Trovagene SWOT Analysis
Table 22. Trovagene Tumor Blood Testing Product and Solutions
Table 23. Trovagene Tumor Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Genomic Health Corporate Information, Location and Competitors
Table 25. Genomic Health Tumor Blood Testing Major Business
Table 26. Genomic Health Tumor Blood Testing Total Revenue (USD Million) (2017-2018)
Table 27. Genomic Health SWOT Analysis
Table 28. Genomic Health Tumor Blood Testing Product and Solutions
Table 29. Genomic Health Tumor Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Pathway Genomics Corporate Information, Location and Competitors
Table 31. Pathway Genomics Tumor Blood Testing Major Business
Table 32. Pathway Genomics Tumor Blood Testing Total Revenue (USD Million) (2017-2018)
Table 33. Pathway Genomics SWOT Analysis
Table 34. Pathway Genomics Tumor Blood Testing Product and Solutions
Table 35. Pathway Genomics Tumor Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Bio-Techne Corporate Information, Location and Competitors
Table 37. Bio-Techne Tumor Blood Testing Major Business
Table 38. Bio-Techne Tumor Blood Testing Total Revenue (USD Million) (2017-2018)
Table 39. Bio-Techne SWOT Analysis
Table 40. Bio-Techne Tumor Blood Testing Product and Solutions
Table 41. Bio-Techne Tumor Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Tumor Blood Testing Revenue (Million USD) by Players (2015-2020)
Table 43. Global Tumor Blood Testing Revenue Share by Players (2015-2020)
Table 44. Global Tumor Blood Testing Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Tumor Blood Testing Revenue Market Share by Regions (2015-2020)
Table 46. North America Tumor Blood Testing Revenue by Countries (2015-2020)
Table 47. North America Tumor Blood Testing Revenue Market Share by Countries (2015-2020)
Table 48. Europe Tumor Blood Testing Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Tumor Blood Testing Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Tumor Blood Testing Revenue by Countries (2015-2020)
Table 51. South America Tumor Blood Testing Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Tumor Blood Testing Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Tumor Blood Testing Revenue Market Share by Countries (2015-2020)
Table 54. Global Tumor Blood Testing Revenue (Million USD) by Type (2015-2020)
Table 55. Global Tumor Blood Testing Revenue Share by Type (2015-2020)
Table 56. Global Tumor Blood Testing Revenue Forecast by Type (2021-2025)
Table 57. Global Tumor Blood Testing Revenue by Application (2015-2020)
Table 58. Global Tumor Blood Testing Revenue Share by Application (2015-2020)
Table 59. Global Tumor Blood Testing Revenue Forecast by Application (2021-2025)
Table 60. Global Tumor Blood Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tumor Blood Testing Picture
Figure 2. Global Tumor Blood Testing Revenue Market Share by Type in 2019
Figure 3. Blood Protein Testing Picture
Figure 4. Tumor Marker Testing Picture
Figure 5. Others Picture
Figure 6. Tumor Blood Testing Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Global Tumor Blood Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Tumor Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Tumor Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Tumor Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Tumor Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Tumor Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Tumor Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Tumor Blood Testing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Tumor Blood Testing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Tumor Blood Testing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Tumor Blood Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Tumor Blood Testing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Tumor Blood Testing Revenue Market Share by Regions in 2018
Figure 24. North America Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 27. South America Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 29. North America Tumor Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Tumor Blood Testing Revenue Market Share by Countries in 2019
Figure 31. USA Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Tumor Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Tumor Blood Testing Revenue Market Share by Countries in 2019
Figure 36. Germany Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 37. UK Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 38. France Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Tumor Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Tumor Blood Testing Revenue Market Share by Countries in 2019
Figure 43. China Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 46. India Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 48. South America Tumor Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Tumor Blood Testing Revenue Market Share by Countries in 2019
Figure 50. Brazil Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Tumor Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Tumor Blood Testing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Tumor Blood Testing Revenue and Growth Rate (2015-2020)
Figure 58. Global Tumor Blood Testing Revenue Share by Type (2015-2020)
Figure 59. Global Tumor Blood Testing Revenue Share by Type in 2019
Figure 60. Global Tumor Blood Testing Market Share Forecast by Type (2021-2025)
Figure 61. Global Blood Protein Testing Revenue Growth Rate (2015-2020)
Figure 62. Global Tumor Marker Testing Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Tumor Blood Testing Revenue Share by Application (2015-2020)
Figure 65. Global Tumor Blood Testing Revenue Share by Application in 2019
Figure 66. Global Tumor Blood Testing Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Tumor Blood Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Tumor Blood Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Tumor Blood Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Tumor Blood Testing Revenue Market Forecast (2021-2025)
Figure 74. Europe Tumor Blood Testing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Tumor Blood Testing Revenue Market Forecast (2021-2025)
Figure 76. South America Tumor Blood Testing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Tumor Blood Testing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
腫瘍学血液検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Oncology Blood Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncology Blood Testing…- 血液凝固検査の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Blood Coagulation Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blood Coagulation T…
- 血糖検査の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Blood Glucose Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 腫瘍切除装置・付属品の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Tumor Ablation Equipment and Accessories market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumo…
- 腫瘍塞栓術の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tumor Embolization market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Embolization market …